By Drug Target Review2024-04-12T12:00:30
Evidence indicating that FOXO1 plays a unique role in promoting T cell longevity could result in more effective CAR T cell therapies.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-26T13:58:00Z
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2023-12-11T10:49:07
Sponsored by Leica Microsystems
2025-08-05T13:42:00
Sponsored by ICON plc., By Drug Target Review
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2023-11-24T12:06:45
Sponsored by Quantum-Si
2023-03-20T13:41:33
Sponsored by Bio-Techne
Site powered by Webvision Cloud